Adverum Biotechnologies
ADVM
ADVM
58 hedge funds and large institutions have $49.5M invested in Adverum Biotechnologies in 2017 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 15 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
33% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 12
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $19K
Holders
58
Holding in Top 10
–
Calls
–
Puts
$19K
Top Buyers
| 1 | +$1.71M | |
| 2 | +$1.52M | |
| 3 | +$1.51M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.3M |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$1.09M |
Top Sellers
| 1 | -$1.25M | |
| 2 | -$1.06M | |
| 3 | -$861K | |
| 4 |
AIC
AWM Investment Company
New York
|
-$500K |
| 5 |
Goldman Sachs
New York
|
-$420K |